After 30 years of growth, we are pleased to announce that effective July 13, 2023, RT Welter and Associates, Inc. will become Welter Healthcare Partners. More Than a Name Change; It’s Who We Are Today.
ARVADA, CO / ACCESSWIRE / July 13, 2023 / We are excited to announce that RT Welter and Associates, Inc. has outgrown its former name and proudly announces its new name: Welter Healthcare Partners.
Our organization was started over 30 years ago by Founder Todd Welter. With Todd’s leadership, we have continuously expanded in scale, capabilities, and client partnerships. Today, we are led by a seasoned executive team overseeing client ROI, daily operations, and customer service, who are now guided and supported by Todd’s new role as our visionary CEO/Chairman.
We adopted a new name that truly embodies who we are today: a team of staff partners providing exceptional customer service and attention to detail for our client partners – a true partnership in success.
We are pleased to announce that effective July 13, 2023, RT Welter and Associates, Inc. will become Welter Healthcare Partners.
For more information, please visit https://welterhp.com/july-13-2023-more-than-a-name-change-its-who-we-are-today/
Contact Information
Jen Heuer
Chief Operating Officer
info@welterhp.com
877-825-8272
SOURCE: Welter Healthcare Partners
View source version on accesswire.com:
https://www.accesswire.com/767721/RT-Welter-and-Associates-Inc-Rebrands-to-Welter-Healthcare-Partners
VANCOUVER, BC / ACCESS Newswire / December 7, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:…
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance…
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…